AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Wyeth updates product labels for its postmenopausal hormone therapies.(Wyeth Pharmaceuticals Proprietary Ltd.)(Brief Article)

Women's Health Weekly

| October 17, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 OCT 17 - (NewsRx.com & NewsRx.net) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that it has updated the package inserts for its postmenopausal hormone therapies Prempro (conjugated estrogens/medroxyprogesterone acetate tablets), Premphase (conjugated estrogens/medroxyprogesterone acetate tablets), and Premarin (conjugated estrogens tablets, USP).

This update reflects recent safety information, primarily from the NIH study known as the Women's Health Initiative (WHI). The company initiated this action so physicians will have up-to-date information in order to counsel their postmenopausal patients on appropriate use of its hormone therapies. Wyeth has sent letters to physicians informing them about the update.

Besides including the WHI findings, the updated labels also state that:

* These products are not indicated and should not be used to prevent coronary ...

Related articles from newspapers, magazines, journals, and more
Supplier updates labels for HRT products. (Rx/Marketplace).(Wyeth...
Magazine article from: Chain Drug Review September 30, 2002 700+ words
...Pa. -- Wyeth Pharmaceuticals has updated...postmenopausal hormone therapies to provide...appropriate use of hormone therapies. Doctors have...postmenopausal hormone therapies, regardless...
Wyeth Pharmaceuticals Calls for Practical Guidance for Women Initiating Hormone...
Press release article from: PR Newswire October 24, 2002 700+ words
...Scientific Workshop on Menopausal Hormone Therapy, Wyeth Pharmaceuticals urged government officials and medical experts to provide...a leader in women's health and markets three leading hormone therapies, Prempro(tm) (conjugated estrogens/medroxyprogesterone...
WYETH PHARMACEUTICALS, MEDIVAS PARTNER ON HEMOPHILIA THERAPIES.
News wire article from: AsiaPulse News February 6, 2007 700+ words
...advanced therapies for hemophilia, Wyeth Pharmaceuticals, a division of Wyeth (NYSE...Manager, BioPharma Business Unit at Wyeth Pharmaceuticals. Under the terms of the agreement...IX, respectively, for life. Wyeth Pharmaceuticals has leading products in the areas...
Wyeth Pharmaceuticals Listed as the Best 10 Pipeline for the Third Consecutive...
Press release article from: PR Newswire January 29, 2007 700+ words
...29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth, , announced...remain an industry leader." About Wyeth Pharmaceuticals Wyeth Pharmaceuticals has leading products in the areas of...
Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop...
Press release article from: PR Newswire February 5, 2007 700+ words
...PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , and Nautilus...Manager, BioPharma Business Unit at Wyeth Pharmaceuticals. Under the terms of this agreement...IX, respectively, for life. Wyeth Pharmaceuticals, a division of Wyeth, has leading...
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop...
Press release article from: PR Newswire February 5, 2007 700+ words
...advanced therapies for hemophilia, Wyeth Pharmaceuticals, a division of Wyeth , announced...Manager, BioPharma Business Unit at Wyeth Pharmaceuticals. Under the terms of the agreement...IX, respectively, for life. Wyeth Pharmaceuticals has leading products in the areas...
Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals...
Press release article from: PR Newswire February 29, 2008 700+ words
...29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today...revert to Solvay Pharmaceuticals. About Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading...
Wyeth Pharmaceuticals Announces First Year Update On Nationwide Bone Mineral...
Press release article from: Business Wire June 12, 2002 700+ words
...women screened in the pilot year of Wyeth Pharmaceuticals' (a division of Wyeth, NYSE...President of Global Medical Affairs for Wyeth Pharmaceuticals. "It is important for a menopausal...by this debilitating disease, Wyeth Pharmaceuticals, a leader in women's health...
For more facts and information, see all results

Source: HighBeam Research, Wyeth updates product labels for its postmenopausal hormone...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA